Ubs Asset Management Americas Inc Tg Therapeutics, Inc. Transaction History
Ubs Asset Management Americas Inc
- $417 Billion
- Q4 2024
A detailed history of Ubs Asset Management Americas Inc transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 272,370 shares of TGTX stock, worth $10.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
272,370
Previous 293,927
7.33%
Holding current value
$10.7 Million
Previous $6.87 Million
19.26%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding TGTX
# of Institutions
372Shares Held
85.5MCall Options Held
3.78MPut Options Held
3M-
Vanguard Group Inc Valley Forge, PA15.6MShares$612 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$447 Million0.0% of portfolio
-
State Street Corp Boston, MA9.2MShares$361 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.19MShares$125 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V82.79MShares$110 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $5.7B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...